Fexet Tablet 60mg, 120mg and 180mg (Fexofenadine)
Getz Pharma (Pvt) LtdDRAP reg. 029435
Prescription required
Getz Pharma’s Pakistani leaflet says Fexet is to be sold on the prescription of a registered medical practitioner only, so we dispense it on prescription.
Same day or next day in Karachi, Lahore, Islamabad, Rawalpindi for orders confirmed before 6pm. Tracked courier, 2 to 4 working days everywhere else. Delivery Rs 250 in Rawalpindi and Islamabad, Rs 300 everywhere else, cash on delivery. Delivery details
Prices in PKR, checked 28 October 2026.
What Fexet is
Fexet (fexofenadine hydrochloride, 60 mg, 120 mg or 180 mg tablets) is a non-sedating antihistamine for the symptoms of hay fever (seasonal allergic rhinitis) and for chronic hives (chronic idiopathic urticaria), according to Getz Pharma’s Pakistani leaflet for Fexet. The leaflet says it is to be sold on prescription only, so we dispense it on prescription.
- Fexet 60mg, 120mg and 180mg are DRAP reg. 029434, DRAP reg. 029435 and DRAP reg. 029436 (DRAP registry entry for 120mg), film-coated tablets of fexofenadine hydrochloride in boxes of 2 or 3 strips of 10.
- Made by Getz Pharma in Karachi: Getz’s own product page lists Fexet as an antihistamine and anti-allergic, in 60 mg, 120 mg and 180 mg tablets.
- Non-sedating: the Pakistani leaflet says fexofenadine has no significant sedative action, though it lists drowsiness among its side effects.
- DRAP notifies no price for Fexet: its price index has no Fexet entry, and the registry gives no approved price.
What is in each tablet
One active ingredient, fexofenadine hydrochloride, from the label claims in DRAP’s registry.
| Tablet | Ingredient | Amount per tablet |
|---|---|---|
| Fexet 60mg (DRAP reg. 029434) | Ingredient: Fexofenadine hydrochloride | Amount per tablet: 60 mg |
| Fexet 120mg (DRAP reg. 029435) | Ingredient: Fexofenadine hydrochloride | Amount per tablet: 120 mg |
| Fexet 180mg (DRAP reg. 029436) | Ingredient: Fexofenadine hydrochloride | Amount per tablet: 180 mg |
What it is used for, and which strength
Pakistan’s leaflet and the UK label match strengths to uses differently, so both are shown. Your doctor chooses the strength.
| Source | Uses and strengths |
|---|---|
| Pakistan, Getz (Fexet) | Symptoms of seasonal allergic rhinitis (hay fever), and the skin symptoms of chronic idiopathic urticaria (hives), in adults and children aged 6 and over. For adults and children 12 and over, the leaflet’s hay fever regimens use the 60 mg or 180 mg tablet and its urticaria regimen the 60 mg tablet; children aged 6 to 11 have a separate regimen at a lower strength. It gives no regimen for the 120 mg tablet. |
| UK, Telfast 120mg and 180mg | 120 mg for hay fever and 180 mg for chronic hives, in adults and children aged 12 and over. |
How to take it
The Pakistani leaflet’s regimens differ by condition and age, so the choice of strength and dose belongs to your prescriber. Take it as they direct.
- With water, before a meal: the UK patient leaflet for Telfast says take the tablet with water before a meal. The Pakistani leaflet gives no instruction about food.
- Fruit juice: the NHS says don’t take fexofenadine with apple, orange or grapefruit juice, as these can reduce how well it works.
- Kidney problems and older people: the Pakistani leaflet gives a lower starting dose for people with reduced kidney function, and says care should be taken in older people, who are more likely to have it.
Who should not take it, or should ask a doctor first
From Getz Pharma’s Pakistani leaflet for Fexet unless another source is named.
- Must not take it: anyone allergic to fexofenadine or any ingredient of the tablet.
- Children under 6: the Pakistani leaflet says safety and effectiveness have not been established.
- Heart disease: the UK label says people with heart disease should be warned that antihistamines as a class have been linked with a fast heartbeat and palpitations.
Other medicines
Indigestion remedies are the only interaction the Pakistani leaflet names.
| Medicine | What the source says | Source |
|---|---|---|
| Antacids containing aluminium or magnesium | What the source says: Reduce the absorption of fexofenadine. The UK label and the NHS say leave about 2 hours between them. | Source: Pakistan; NHS |
| Erythromycin, ketoconazole | What the source says: Raise fexofenadine levels in the blood 2 to 3 times, without effects on the heart’s QT interval or more side effects. | Source: UK, 4.5 |
Pregnancy and breastfeeding
Ask your doctor before taking it if you are pregnant or breastfeeding.
| Who | What the sources say |
|---|---|
| Pregnancy | Pakistan: only if the potential benefit justifies the potential risk to the baby. UK: should not be used unless clearly necessary. |
| Breastfeeding | Pakistan: caution should be exercised. UK: not recommended. NHS: you can take it if you need to while breastfeeding, though other antihistamines might be better. |
Side effects
Headache, drowsiness, nausea, vomiting, tiredness and dizziness, according to Getz Pharma’s Pakistani leaflet for Fexet.
Driving: the UK product information for fexofenadine (Telfast) says fexofenadine is unlikely to affect driving, but advises checking how you respond before driving or doing complicated tasks. The Pakistani leaflet has no driving section.
Fexet-D: a separate decongestant product
Fexet-D (DRAP reg. 039099) contains fexofenadine 60 mg with pseudoephedrine 120 mg. Getz’s Pakistani leaflet for Fexet-D says it is for allergic rhinitis with a blocked nose, in adults and children aged 12 and over, when both an antihistamine and a decongestant are needed.
- Must not take it: the Fexet-D leaflet says people with narrow-angle glaucoma, difficulty passing urine, severe high blood pressure or severe coronary artery disease, and anyone taking an MAO-inhibitor antidepressant or who stopped one in the last 14 days.
- DRAP’s 2024 safety alert on pseudoephedrine medicines says they are not to be used with severe or uncontrolled high blood pressure or severe kidney disease, and to stop and seek urgent help with a sudden severe headache, sickness, confusion, fits or changes in vision.
- Pseudoephedrine is a controlled substance in Pakistan: DRAP’s quota rules for controlled substances cover it.
- We don’t sell Fexet-D online. Ask our pharmacist on WhatsApp if it has been prescribed for you: they check your blood pressure, heart and other medicines first.
Checking your pack is genuine
DRAP has named one spurious batch of Fexet 120mg, F26018. If your pack’s batch number is F26018, do not take it.
- Check that the batch number on the box matches the batch number on the strip inside, and that the pack is sealed.
- Fexet comes in boxes of 2 or 3 strips of 10 tablets, according to DRAP’s registry. If a pack looks different from your last one, ask our pharmacist before taking it.
- If anything looks wrong, do not take it. Send us a photo of the box and strip on WhatsApp, and report it to DRAP.
DRAP Rapid Alert No. I/S/09-25-59, 10 September 2025: Fexet tablets 120mg, batch F26018, purported to be made by Getz Pharma, declared spurious by the Drug Testing Laboratory, Punjab.
We buy only from authorised distributors, and check the batch and expiry on every item before it is packed.
Information as of 28 October 2026. DRAP publishes new alerts on dra.gov.pk.
Returns and replacements
Medicines and supplements can’t be returned once they have left our pharmacy.
- Returned medicine can never go back into saleable stock. That is a safety rule, not a commercial one.
- If an item arrives damaged or wrong, tell us on WhatsApp within 24 hours and we replace it. That is us fixing our mistake, not a return.
- Anything that arrives expired or within a month of expiry we replace or refund, your choice, with no time limit.
Frequently asked questions
What is Fexet tablet used for?
Fexet is fexofenadine, an antihistamine. Getz Pharma’s Pakistani leaflet lists the symptoms of seasonal allergic rhinitis (hay fever) and the skin symptoms of chronic idiopathic urticaria (hives), in adults and children aged 6 and over.
Does Fexet cause sleepiness?
It is described as non-sedating: Getz’s Pakistani leaflet says fexofenadine has no significant sedative action. Its leaflet still lists drowsiness and dizziness as side effects, so see how it affects you before driving.
What is the difference between Fexet and Fexet-D?
Fexet-D adds pseudoephedrine, a decongestant, to fexofenadine. It has its own warnings, including severe high blood pressure, severe coronary artery disease and glaucoma, and we don’t sell it online.
Can I take Fexet with orange juice?
The NHS says don’t take fexofenadine with apple, orange or grapefruit juice, as these can reduce how well it works. Take it with water.
Do you need a prescription to buy Fexet?
Yes. Getz Pharma’s Pakistani leaflet says Fexet is to be sold on the prescription of a registered medical practitioner only.
Related products
Rigix Tablets 10mg
30 tablets
In stock
Rs 390
See Rigix
Kestine Tablets 10mg and 20mg (Ebastine)
Prescription required
10mg, 14 tablets
In stock
Rs 298
See Kestine
Rigix Oral Solution
Oral solution, 120 ml
In stock
Rs 200
Softin Tablet 10mg (Loratadine)
10 tablets
In stock
Rs 100
See Softin
Myteka Tablet 10mg (Montelukast)
We dispense this on prescription
10mg, 14 tablets
In stock
Rs 554
See Myteka
Questions about Fexet Tablet 60mg, 120mg and 180mg (Fexofenadine)?
Send your question on WhatsApp and a pharmacist will come back to you.
Written by the ePharmacyy pharmacy team.
Last checked against the sources below on
DRAP registration
- Fexet Tablet 120mg (029435), Getz Pharma (Pvt.) Ltd. DRAP’s registry shows: Active, “Approved / Verified”.
- Fexet Tablet 60mg (029434), Getz Pharma (Pvt.) Ltd. DRAP’s registry shows: Active, “Approved / Verified”.
- Fexet Tablet 180mg (029436), Getz Pharma (Pvt.) Ltd. DRAP’s registry shows: Active, “Approved / Verified”.
- Fexet-D Tablets 60mg + 120mg (039099), Getz Pharma (Pvt) Limited. DRAP’s registry shows: Provisionally Active, “Not Verified”.
DRAP publishes no definition of this verification flag, so we can’t tell you what it means. We searched DRAP’s website for “Fexet”, “fexofenadine”, “Getz” and “pseudoephedrine” on 28 October 2026 and found one alert naming a spurious batch of Fexet 120mg, F26018 (below), and a safety alert about pseudoephedrine medicines, which applies to Fexet-D. When we tested it, the search did not find a word that appears only inside an alert’s attached PDF, so an alert that names a product only in its PDF may not show up. DRAP describes its registered products index as a provisional list that “cannot be used as a reference for any purpose”. Checked against the registry on .
Sources
- DRAP registered products: Fexet Tablet 60mg, registration 029434
- DRAP registered products: Fexet Tablet 120mg, registration 029435
- DRAP registered products: Fexet Tablet 180mg, registration 029436
- DRAP registered products: Fexet-D Tablets 60mg + 120mg, registration 039099
- DRAP notified price index (no Fexet entry, searched 28 October 2026)
- Getz Pharma: Fexet product page (Pakistan)
- Getz Pharma: Fexet tablets, Pakistani leaflet (L-200008371)
- Getz Pharma: Fexet-D tablets, Pakistani leaflet (L-200008378)
- emc (UK): Telfast 120mg tablets, summary of product characteristics (revised 22 September 2025)
- emc (UK): Telfast 120mg tablets, patient information leaflet (revised July 2025)
- emc (UK): Telfast 180mg tablets, summary of product characteristics (revised 22 September 2025)
- NHS: Fexofenadine
- NHS: How and when to take fexofenadine
- NHS: Taking fexofenadine with other medicines and herbal supplements
- NHS: Pregnancy, breastfeeding and fertility while taking fexofenadine
- DRAP drug safety alert: PRES and RCVS with pseudoephedrine-containing medicines (2024)
- DRAP: SOP for quota allocation of controlled substances for local consumption
- DRAP Rapid Alert I/S/09-25-59: spurious and falsified products declared by provincial laboratories (10 September 2025)